We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $128M
1-Year Est. Return 9.54%
This Fund
S&P 500
This Quarter Est. Return
-13.46%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$444M
AUM Growth
-$166M
Cap. Flow
-$68M
Cap. Flow %
-15.33%
Top 10 Hldgs %
54.9%
Holding
59
New
7
Increased
7
Reduced
15
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$24.7M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$16.5M
3
HUM icon
Humana
HUM
+$15.6M
4
PODD icon
Insulet
PODD
+$9.32M
5
CHTR icon
Charter Communications
CHTR
+$7.56M

Top Sells

Rank Stock Value
1
ROST icon
Ross Stores
ROST
+$27.9M
2
LKQ icon
LKQ Corp
LKQ
+$16.5M
3
GDDY icon
GoDaddy
GDDY
+$14.1M
4
DG icon
Dollar General
DG
+$13.6M
5
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$9.53M

Sector Composition

Rank Sector Weight
1 Healthcare 46.43%
2 Technology 21.21%
3 Financials 8.01%
4 Communication Services 7.2%
5 Consumer Staples 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRBR icon
26
BellRing Brands
BRBR
$1.47B
$4.66M 1.05%
187,122
– –
DCBO
27
Docebo
DCBO
$520M
$4.31M 0.97%
150,300
+46,600
+45% +$1.77M
RCM
28
DELISTED
R1 RCM Inc. Common Stock
RCM
$3.9M 0.88%
+186,000
New +$4.22M
LIVN icon
29
LivaNova
LIVN
$4.42B
$3.49M 0.79%
55,890
+16,990
+44% +$1.2M
XENE icon
30
Xenon Pharmaceuticals
XENE
$6.1B
$2.35M 0.53%
+77,400
New +$2.34M
QTRX icon
31
Quanterix
QTRX
$164M
$2.34M 0.53%
144,684
+51,500
+55% +$1.06M
MSOS icon
32
AdvisorShares Pure US Cannabis ETF
MSOS
$856M
$2.22M 0.5%
214,100
– –
SRZN icon
33
Surrozen
SRZN
$254M
$2.1M 0.47%
46,667
– –
ABCM
34
DELISTED
Abcam PLC
ABCM
$2.06M 0.46%
142,350
– –
DMTK
35
DELISTED
DermTech, Inc. Common Stock
DMTK
$1.94M 0.44%
350,800
-18,400
-5% -$151K
PRVA icon
36
Privia Health
PRVA
$2.98B
$1.29M 0.29%
44,400
-85,900
-66% -$2.18M
IMGN
37
DELISTED
Immunogen Inc
IMGN
$1.25M 0.28%
278,000
-224,000
-45% -$973K
NAUT icon
38
Nautilus Biotechnolgy
NAUT
$126M
$777K 0.18%
289,000
– –
VRDN icon
39
Viridian Therapeutics
VRDN
$2.1B
$767K 0.17%
+66,300
New +$891K
NEXI
40
DELISTED
NexImmune, Inc. Common Stock
NEXI
$644K 0.15%
16,000
– –
TECH icon
41
Bio-Techne
TECH
$11.2B
$501K 0.11%
5,776
-20,968
-78% -$1.97M
SRZNW icon
42
Surrozen Inc Warrant
SRZNW
$69.7K
$89K 0.02%
466,666
– –
WRAC.WS
43
DELISTED
Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
WRAC.WS
$40K 0.01%
475,000
– –
AMZN icon
44
Amazon
AMZN
$2.92T
– –
-13,040
Closed -$2.13M
CF icon
45
CF Industries
CF
$19.2B
– –
-24,380
Closed -$2.51M
CRM icon
46
Salesforce
CRM
$151B
– –
-33,500
Closed -$7.11M
DG icon
47
Dollar General
DG
$28B
– –
-60,900
Closed -$13.6M
GDS icon
48
GDS Holdings
GDS
$6.49B
– –
-150,000
Closed -$5.89M
LKFT
49
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.79B
– –
-153,700
Closed -$9.53M
GOOGL icon
50
Alphabet (Google) Class A
GOOGL
$4.33T
– –
-6,880
Closed -$957K
1
2
3

Similar funds

SHFC
Safe Harbor Family Capital Chapel Hill, North Carolina $128M AUM
IUC
Ivory Union Consulting Road Town $128M AUM
PC
Pelham Capital London, United Kingdom $128M AUM 34.73% 1-Year Est. Return
SIM
Summitas Investment Management Mckinney, Texas $128M AUM
PIA
Prakash Investment Advisors Andover, Massachusetts $128M AUM 44.06% 1-Year Est. Return
S
Storgate Dallas, Texas $127M AUM
CF
Concorde Financial Dallas, Texas $127M AUM 24.97% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return

Bridger Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bridger Management held 59 positions worth $444M, down 27% from $610M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Bridger Management withdrew a net $68M in Q2 2022, closing 16 positions and reducing 15 holdings. Its most notable exit was Ross Stores, an estimated $27.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 34% a quarter earlier, followed by Technology and Financials.

Against the trend, Bridger Management opened a new position in AstraZeneca worth $24.9M.

  • Bridger Management's largest Q2 2022 buy was AstraZeneca: 188,300 shares worth $24.9M.
  • Bridger Management added most to Charter Communications in Q2 2022, an estimated $7.56M increase.
  • Bridger Management's biggest Q2 2022 reduction was GoDaddy, cutting an estimated $14.1M.
  • Bridger Management fully exited Ross Stores in Q2 2022, selling an estimated $27.9M.
  • Bridger Management's ten largest holdings make up 55% of its $444M portfolio in Q2 2022.
  • Bridger Management opened 7 new positions and closed 16 in Q2 2022.
  • Bridger Management's portfolio value fell 27% quarter-over-quarter to $444M.

Based on Bridger Management's 13F filing for Q2 2022, filed 15 Aug 2022.